AFT Forsyth & Company’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$310K Hold
552
0.15% 101
2025
Q4
$373K Hold
552
0.16% 91
2025
Q3
$353K Buy
552
+10
+2% +$6.07K 0.17% 88
2025
Q2
$291K Sell
542
-155
-22% -$74.1K 0.15% 96
2025
Q1
$293K Sell
697
-75
-10% -$32.6K 0.16% 103
2024
Q4
$319K Sell
772
-285
-27% -$125K 0.16% 105
2024
Q3
$534K Sell
1,057
-65
-6% -$31.6K 0.26% 80
2024
Q2
$547K Buy
1,122
+20
+2% +$10K 0.27% 78
2024
Q1
$595K Sell
1,102
-180
-14% -$98.4K 0.34% 72
2023
Q4
$712K Hold
1,282
0.45% 62
2023
Q3
$561K Hold
1,282
0.41% 65
2023
Q2
$644K Buy
1,282
+85
+7% +$40.7K 0.46% 62
2023
Q1
$599K Sell
1,197
-7
-0.6% -$3.35K 0.46% 63
2022
Q4
$491K Sell
1,204
-53
-4% -$20.6K 0.42% 72
2022
Q3
$410K Buy
1,257
+15
+1% +$5.51K 0.37% 84
2022
Q2
$436K Buy
1,242
+94
+8% +$38.3K 0.35% 83
2022
Q1
$628K Buy
1,148
+35
+3% +$18.4K 0.4% 68
2021
Q4
$733K Sell
1,113
-80
-7% -$50.2K 0.38% 79
2021
Q3
$742K Buy
1,193
+470
+65% +$316K 0.4% 79
2021
Q2
$457K Buy
723
+260
+56% +$144K 0.24% 113
2021
Q1
$227K Buy
+463
New +$232K 0.14% 142

Other funds holding IDXX

AFT Forsyth & Company's IDXX Position: Q1 2026 in Review

AFT Forsyth & Company held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 552 shares worth $310K. The position accounts for 0.15% of the portfolio, ranked #101.

AFT Forsyth & Company first reported a position in IDXX in Q1 2021 and has held it in 21 quarters since. The position peaked at $742K in Q3 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • AFT Forsyth & Company held 552 shares of Idexx Laboratories worth $310K as of Q1 2026.
  • AFT Forsyth & Company left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.15% of AFT Forsyth & Company's portfolio in Q1 2026, its #101 holding.
  • AFT Forsyth & Company first reported a position in Idexx Laboratories in Q1 2021 and has held it in 21 quarters since.
  • AFT Forsyth & Company's Idexx Laboratories position peaked at $742K in Q3 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on AFT Forsyth & Company's 13F filing for Q1 2026, filed 14 May 2026.